Japanese researcher Haruko Obokata is caught in a fix, yet again. The Harvard-trained scientist became a phenomenon with her “acid-shock” research in January 2014, which provided a blueprint for growing new organs and replacing injured cells. Now, Waseda University in Japan has announced a revocation of her doctorate over “copyright infringements and flaws,” in her groundbreaking stem cell research, reports Al Jazeera.

In 2014, Waseda University had told Obokata to rectify the errors in her thesis. Kaoru Kamata, president of the university, announced the revocation of her doctorate on Nov. 2, after she missed the deadline on Oct. 31. Obokata has reportedly opposed the action and said that she is considering taking the institution to court.

Japan’s Riken Institute – a research organisation involved in various scientific disciplines – had acclaimed Obokata’s study that involved programming mature cells into working like stem cells, reports ABC News. The research involved allowing skin and blood cells to multiply, then subjecting it to high levels of stress – close to the point of causing cell death. This was done by exposing it to numerous events such as low oxygen levels, trauma and acidic surroundings. As a part of the experiment, the cells were bathed in a weak acid solution for nearly 30 minutes. Scientists had claimed that not only had the cells survived, but also recovered by returning to a state similar to an embryonic cell.

However, her papers on Stimulus-Triggered Acquisition of Pluripotency (STAP) caused doubts to emerge. Errors were discovered in the data of two papers, photo captions were found to be deceptive, but most importantly, other scientists could not reproduce the results. Later, Obokata herself failed to successfully replicate the conversion of a mature cell into a state similar to a stem cell, also called STAP cells.

The failure prompted her co-researcher to commit suicide amidst the stem cell research scandal, while Obokata resigned from Riken, reports Al Jazeera.

Contact the writer at [email protected], or let us know what you think below